Page 143 - 71_02

VOL. 71 (2), 387-427, 2005 LA TOXINA BOTULÍNICA COMO MEDICAMENTO

(45) GELFOND, M.; ROZEN, P.; GILAT, T. (1982): Isosorbide dinitrate and nifedipine
treatment of achalasi: a clinical, manometric and radionuclide evaluation.
(46) Gastroenterology 83: 963-969.
GOLDBLUM, J. R.; WHYTE, R. I.; ORRINGER, M. B.; APPELMAN, I. D. (1994): Acha-
(47) lasia. A morphologic study of 42 resected specimens. Am J Surg Pathol 18:
327-337.
(48) GOLDBLUM, J. R.; RICE, T. W.; RICHTER, J. E. (1996): Histopathologic features
(49) in esop-hagomyotomy specimens from patients with achalasia. Gastroente-
rology 111: 648-654.
(50) GOLDSTEIN, J. L.; YERSON, R. G.W.; BROWN, M. S. (1979): Coated pits, coated
vesicles Y receptor-mediated endocytosis. Nature. 279: 679-689.
(51) GÓMEZ DE LIAÑO SÁNCHEZ, R.; RODRÍGUEZ SÁNCHEZ, J. M.; DE ANDRÉS, M. L. Y
(52) COL. (1996): Tratamiento del estrabismo convergente con cirugía o con toxi-
na botulínica. Acta Estrabológica 1996; 25: 147-153.
(53) GÓMEZ VILLAESCUSA, F.; GARCÍA GARCÍA, N.; ARIAS LÓPEZ, M. C. (1996): Estudio
(54) de pacientes inicialmente tratados con toxina botulínica y que han precisa-
do cirugía convencional. Acta Estrabológica 25: 107-153.
(55) GORDON, M.; EAKER, E. Y. (1997): Prospective study ofesophageal botulinum
(56) toxin injection in high risk. Dig Dis Sci. 42: 724-7.
(57) GRIMAUD, J. C.; BOUVIER, M.; NAUDY, B. Y COLS. (1991): Manometric and radio-
(58) logic investigations and biofeed-back treatment of chronic idiopathic anal
(59) pain. Dis Colon Rectum; 34: 690-695.
HABERMANN, E. (1974): 120I labeled neurotoxin from Clostridium botulinu A.
(60) Arch Pharmakol. 281: 47.
(61) HABERMANN, E. (1989): Clostridial neurotoxins and the central nervous
system: Funccional studies on isolated preparations. En: Simpson LL, ed.
Botulinum Neurotoxin and Tetanus Toxin. New York, NY: Academic Press,
Inc. 53-67.
HARVEY, S. M.; STURGEON , J.; DASSEY, D. E. (2002): Botulism due to Clostri-
dium baratii type F toxin. J Clin Microbiol. 40: 2260-2.
HASHIMOTO, T.; UCHIDA, Y.; NOGUCHI, T.; TAHARA, K. (2000): Clinical manage-
ment of esophageal achalasia. Nippon Geka Gakkai Zashi 101: 342-344.
HAUSOR, D.; POPOFF, M. R.; KURAZONO, H. Y COL. (1990): Complete sequence
of botulinal C1 neurotoxin. Nucleic Acids Res. 18: 4924-4928.
HENDERSON, R. D.; RYDER, D. E. (1982): Reflux Control Following myotomy
in diffuse Esophageal Spasm. Ano Thorac Surg 34 (3): 230-236.
HIRASHIMA, T.; SATO, H.; RARA, T.; NAKAMURA, H.; KAWAMURA, L.; TAKEUCHI, H.;
MUTO, M.; OHKAWA, H. (1978): Results of Esophagocardioplsty with Gastric
Parch in the Treatment of Esophageal Achalasia. Ann Surg 188: 38-42.
HOLZMAN, M. D.; SHARP, K. W.; ELLER, R. F. (1997): Laparoscopic surgical
treatment of achalasia. Am J Surg 173: 308-311.
HOOGERWERF, W. A. PASRICHA, P. J. (2000): Achalasia: treatment options re-
visited. Can J Gastroenterology 14: 406-409.

423